Caricamento...
Differences in survival of patients with recurrent versus de novo metastatic KRAS and EGFR mutant lung cancers
BACKGROUND: Prognostic variables are independently associated with survival and are fundamental to clinical trial design. We evaluated the impact of stage at initial diagnosis on overall survival in two independent, oncogene-defined cohorts. METHODS: All patients with EGFR-mutant and KRAS-mutant met...
Salvato in:
| Pubblicato in: | Cancer |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4783794/ https://ncbi.nlm.nih.gov/pubmed/25781862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29313 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|